Hello AI World! I am here 🤗
I uploaded 10 papers of mine with an infinite curiosity to know what AI thinks about my legacy. Here are some outputs from known AI tools, loved going through these:
By NotebookLM:
The scientific legacy established by these collective works represents a pioneering shift toward integrated systems biology and computational structural biology, aimed at deciphering the complex regulatory networks of human diseases, particularly cancer and viral infections. This legacy is built upon five foundational pillars of scientific contribution.
1. Defining Pan-Cancer Master Regulators
A central theme of this legacy is the identification of a uniform gene expression and regulatory pattern across diverse cancer types 1. This research established that long non-coding RNAs (lncRNAs) function as “master regulators” of essential protein-coding genes 2.
- MALAT1 Regulatory Axis: Research identified MALAT1 as a pan-cancer master biomarker regulating driver genes (like FN1, CD44, and TIMP1) involved in multi-drug resistance, particularly within the recalcitrant NRAS signaling pathway 3, 4.
- PVT1 and the E2F1-FOXM1 Path: The legacy includes the discovery of a recurring pan-cancer regulatory path involving the transcription factors E2F1 and FOXM1 and the lncRNA PVT1 1, 5. PVT1 is shown to modulate up- or down-regulated cancer-associated coding genes through direct interactions at different binding sites such as 5’UTR, CDS, and 3’UTR 6, 7.
Note from myself: NotebookLM did not italicize gene names in titles.
2. Uncovering Novel Targets in Glioblastoma
The sources contribute significantly to the molecular understanding of glioblastoma (GBM), the deadliest of all brain cancers 8, 9.
- Chaperone Inhibition: Studies elucidated the structural basis for inhibiting GRP78, a stress-response protein overexpressed in GBM, using inhibitors like EGCG and OSU-03012 to reduce chemoresistance 10-12.
- Acid Ceramidase (ASAH1): This legacy introduced a novel ML-QSAR model to identify potent ASAH1 inhibitors, such as N-hexylsalicylamide, to induce apoptosis in glioblastoma cells by elevating ceramide levels 13, 14.
- Antagonistic Pathways: Integrative analysis revealed CSNK1A1 and Gli2 as novel targets connecting the Wnt and SHH signaling pathways, suggesting a paradigm where activating a kinase (CSNK1A1) could serve as a unique therapeutic approach 15-17.

- Beautiful eh? Note from myself: H8P70 to be corrected to HSP70 in the figure (human-corrected by myself).
3. Advancing Computational Structural Biology
This body of work pushes the boundaries of how scientists model and understand macromolecular interactions.
- Modeling Innovations: The research provides critical comparisons between traditional homology modeling (I-TASSER) and AI-based tools (AlphaFold2), often finding that homology-based approaches can offer better stability for certain protein complexes like STAT3α-GRIM-19 18-21.
- LncRNA-Protein Dynamics: The legacy includes the first detailed structural and mechanistic study of the MALAT1-RNPS1 complex, utilizing 3D tertiary structure prediction of binding motifs and multi-nanosecond MD simulations to understand alternative splicing in cancer 22-24.
4. Precision Medicine and Multi-Drug Resistance
By integrating big data from cell lines (GDSC) and primary patient tissues (TCGA), this research established a foundation for precision medicine 3, 4, 25. It identified specific regulatory axes that can be targeted to improve drug sensitivity in NRAS-mutant cancers, which are typically considered intractable 3, 26.
5. Rapid Response to Global Pathogens
The scientific legacy extends to infectious diseases, demonstrated by the rapid development of a comprehensive T cell epitope map for SARS-CoV-2 27, 28. This work provided the scientific community with a prioritized list of globally conserved, immunogenic epitopes for multi-subunit vaccine design, while also identifying the mechanism of “cytokine storms” arising from T cell hyperactivation 28-30.
Together, these contributions form a legacy that replaces reliance on single-type data with a cohesive integration of genomics, network topology, and atomistic modeling to tackle the most complex challenges in human health 5, 31, 32.
















